Immunological aspects of candidal vaginitis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007501:Iron / Q000009:adverse effects*; D000090463:Iron Deficiencies; D007978:Levamisole / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D007978:Levamisole; D007501:Iron